Not only did it call for lower doses (As a result lowering the prospect of Negative effects), but CBDA was more practical in seizure reduction in certain parameters. A number of this facts seems in GW’s patent application4 to the ‘Use of cannabinoids while in the therapy of epilepsy,’ in https://andresteoxj.dgbloggers.com/33351316/the-best-side-of-terpenes